Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

Baricitinib is effective and safe for treating severe alopecia areata.

Baicalin may help reduce excessive male hormone levels in PCOS.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

A new compound shows promise as a topical treatment for hair loss.

Baricitinib successfully treated severe hair loss.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Cyproterone acetate was effective in treating acne, hirsutism, and alopecia with few side effects.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Six months of treatment improved PCOS symptoms and reduced AMH levels.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

A new liposomal formulation improves drug delivery and hair growth for treating hair loss without causing skin irritation.

Blocking cholesterol production may help control hair loss in Primary Cicatricial Alopecia by affecting key regulators.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Cyproterone acetate is used for topical treatment of diseases dependent on male hormones.